"Epidemic Bubble" blessing!Wenjiang Biomedical Enterprise "closed -loop" production and development

Biomedical is not only an important emerging industry, but also the basic industry to protect the health of the people. As the city's biomedical health industry highland, 24 biomedical companies in Wenjiang have set up a closed -loop production model of "epidemic prevention bubbles" to ensure the innovative research and development power and production and supply capabilities during the epidemic, and go all out to protect the "lifeline".

"At present, senior scientists in our key projects are promoting research and development, eating, housing, and work in the company, in order to not delay the progress of the development of new drugs."

In the laboratory of Sichuan Creard Botai Biomedical Co., Ltd., Yang Qiuyan, Minister of Production Management Department of the Company, and more than 200 scientists with more than two hundred scientists to develop and produce the company's 14 types of innovative drugs approved by clinical research and production of clinical samples Essence These drugs cover a number of major diseases such as malignant tumors, autoimmune, anesthesia analgesics.

Sichuan Kelunbo, located in Chengdu Medical City, is a holding subsidiary of the Coren Pharmaceutical (SZ002422). It focuses on the research and development, production and commercialization of innovative biotechnology drugs and innovative chemicals. At present, the company has conducted more than 30 research on innovative drugs, and 14 innovative drugs have been approved by clinical trials. It can be said that Coronbo Thai is the "R & D Center" and "the strongest brain" of Coron Pharmaceutical.

"These 14 clinical trials have a long R & D project R & D cycle. The single preparation conditions for clinical samples are complex and the process is complicated. Generally, the single preparation requires continuous continuously without 45 days, and the production cost of a single batch is more than 10 million yuan ... "Yang Qiuyan told reporters that such a high requirement and high investment required this batch of clinical sample production once it was started, and they could not stop. The personnel needed for 24 hours to follow the operation and the machine was operated by the axis. And the preparation progress of each clinical sample will be directly related to the progress of clinical research on hundreds of hospitals.

In order to escort the development of new drugs and the production of clinical samples, Columbal Botai launched an emergency mechanism as soon as possible. In the closed companies, not only do more than 200 scientists eat and live here, but also more online office scientists stick to the front line of research and development. The research and development of new drugs with global racing did not suspend the epidemic raid.

While the R & D work is steadily promoted, production is also running at full load. Sichuan Kelun Doushan Biotechnology Co., Ltd., which is adjacent to Kelun Botai, operates at the full load of the production line. 90%of the company's employees eat, live and produce in the factory, and produce egg yolk lecithin with an annual production capacity of 50 tons (for injection) Essence

It is understood that egg yolk lecithin (for injection) is a necessary auxiliary material for first -line anti -epidemic drugs. It is mainly used in fat dairy nutrients products. It cannot be used after surgery and cannot be used by patients with severe patients. Shi Bin, deputy general manager of the company, said that the company established the "epidemic prevention bubble" system to effectively ensure the smooth progress of research and development and production, and reduce the impact of the epidemic. "The company has successfully launched a closed -loop production, which is inseparable from the support of the relevant departments of Wenjiang District. It guides us to do a good job in the prevention and control of the epidemic, arrange a special person's" point -to -point "on -door nucleic acid testing, and assist in applying for a confession vehicle permit ..."

Similar to the situation of Coron Doushan, Chengdu Tongde Pharmaceutical Co., Ltd. also launched a closed -loop production of "epidemic prevention bubbles" on September 1st, mainly producing 3 drugs for winning nationals and more than 10 first -aid anti -infection medicines. Satisfy the daily medication of the people and the emergency rescue of the hospital. Peng Jia, director of the company's financial director, said: "Compared to usual, in the closed -loop production model, in order to ensure production, the company's production and necessary positions are stationed in the factory. Therefore, we have not cut production capacity."

At present, the company's injection workshop produces 400,000 medicines per day, a small -capacity injection workshop produces 600,000 drugs per day, and oral solid -making workshop produces 2 million tablets per day.

The epidemic should be defended, the economy must be stable, and the development is safe. As the main position of Chengdu Biomedical Health Industry, Wenjiang has gathered nearly 520 leading enterprises and upstream and downstream collaborative companies, "Fortune 500" and 11 pharmaceutical industry. Gathering the world's leading CRO companies, Pharmaceutical Kant, the top 100 Chinese pharmaceutical industry Kollen, Luo Xin, Hylosko, Weiya, Kanghua and other listed pharmaceutical companies.

"The biomedical industry is both the leading industry of Wenjiang and the people's livelihood guarantee industry. It is especially important to stabilize their production during the epidemic. At present, 24 biomedical companies have started closed -loop production, involving 3259 employees." Chengdu Medical City Management Committee is responsible for responsibility People said that in order to ensure that the key industries are constantly produced at critical moments, the relevant departments of our district will assist enterprises to complete the closed -loop production declaration work as soon as possible to help enterprises apply for a logistics vehicle emergency transportation permit, provide material procurement channels, and conduct nucleic acid testing on closed -loop production personnel to perform nucleic acid testing on their door. , Consolidated production and epidemic prevention work on -site guidance and other policies and assistance work.

Next, Chengdu Medical City will do a good job of preventing and controlling the epidemic and production development. Through the establishment of a strong chain of the circle, the strong support of the tackling project, the difficulty of relieving the rescue and solving the growth, making a greater contribution to the development of Wenjiang's economic development.

Reporter Chen Shen

- END -